Showing results (981-990 of 1,376) with videos related to
Sort By:
Pageof 138
Drug Development Research|April 6, 2026
Design and Development of PLGA-PEG-FA Nanoparticles Encapsulating Noscapinoids for Receptor-Mediated Breast Cancer TreatmentNamita Bhoi, Pradeep Kumar NaikDrug Development Research|May 3, 2026
Design, Synthesis, Biological Evaluation, and Molecular Modeling Studies of Novel 2-Aminothiazole Derivatives as Potential FOXM1 Inhibitors for Triple-Negative Breast Cancer Therapy and Structure-Activity RelationshipKhaled A N Abusharkh, Venhar Çınar, Alper Onder, et al.Drug Development Research|May 3, 2026
Antitumor Activity of Sodium Selenite, Palbociclib, and Disulfiram Against Osteosarcoma and Rhabdomyosarcoma Cell LinesMaría Ángeles Chico, Kevin Doello, Raul Ortiz, et al.Drug Development Research|May 3, 2026
Structure-Guided Design and Mechanistic Elucidation of New Chromene Derivatives as Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors With Potent Anticancer ActivityHazem Elkady, Walid E Elgammal, Ibrahim H Eissa, et al.Drug Development Research|April 20, 2026
Cyclophosphamide Induces Autophagy-Dependent Ferroptosis Through Promoting ETNK1 Expression in Breast Cancer CellsJiacheng Shen, Aifeng Qiu, Xiaobing Liu, et al.Drug Development Research|May 18, 2026
Kv1.3 Channel Blockade by Dalfampridine Attenuates NLRP3 Inflammasome-Driven Demyelination via the NEK7/Ripk1/FADD Pathway, Matching the Efficacy of Broad P2X7 Antagonism by Suramin in EAEAhmed S Kamel, Heba Nasr Shalaby, Yasmin A M El-Said, et al.Drug Development Research|May 12, 2026
Nanoplatform-Based Delivery Systems for PROTACsWenbo Che, Xinlin Wang, Sijin Chen, et al.Drug Development Research|June 1, 2026
New Treatment Approach Using Peptoid-Based Vaccines in Parkinson's DiseaseSeyedeh Toktam Ekrani, Tola Abdulsattar Faraj, Chnar Husam Taha, et al.Drug Development Research|May 10, 2011
In Silico Augmentation of the Drug Development Pipeline: Examples from the study of Acute InflammationGary An, John Bartels, Yoram VodovotzDrug Development Research|June 18, 2026
Selenium-Containing 1,4-Naphthoquinone Derivatives Trigger Reactive Oxygen Species and Apoptosis in Triple-Negative Breast Cancer CellsEduardo Angulo-Elizari, Asif Raza, Hannah Johnson, et al.Pageof 138